ProShares UltraShort NASDAQ Biotechnology
10 hedge funds and large institutions have $3.17M invested in ProShares UltraShort NASDAQ Biotechnology in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$990K | |
| 2 | +$959K | |
| 3 | +$238K | |
| 4 |
IMC Chicago
Chicago,
Illinois
|
+$39.4K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$2.1K |
Top Sellers
| 1 | -$351K | |
| 2 | -$98.3K | |
| 3 | -$54K | |
| 4 |
WP
WealthSource Partners
San Luis Obispo,
California
|
-$42K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$21K |